A Safety Extension Study in Patients With Erythropoietic Protoporphyria (EPP)

Clinical trial NCT04578496 · COMPLETED

Trial details

NCT number: NCT04578496
Sponsor: Clinuvel Pharmaceuticals Limited
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Erythropoietic Protoporphyria

Start date: 2011-07-11
Primary completion: 2014-02-27
Enrollment: 16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.